Biomea Fusion (BMEA) Earnings Date & Reports

Biomea Fusion Inc is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small-molecule drugs to treat patients with metabolic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BMEA is expected to report earnings to fall 35.50% to -51 cents per share on August 04

Biomea Fusion BMEA Stock Earnings Reports

Q2'25

Est.

$-0.52

Q1'25

Beat

by $0.12

Q4'24

Beat

by $0.10

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.05

The last earnings report on May 05 showed earnings per share of -80 cents, beating the estimate of -91 cents. With 195.06K shares outstanding, the current market capitalization sits at 66.50M.

View a ticker or compare two or three

Compare

BMEA